Issue 1322: August 23, 2017

Ask the Experts
Ask the Experts—Question of the Week: Is there any plan to change the Influenza Vaccine Information Statement (VIS) . . . read more









National Immunization Awareness Month is wrapping up, with the final week focusing on vaccinations for preteens and teens

Every year in August, National Immunization Awareness Month (NIAM) provides an opportunity to raise awareness about the importance of immunization and the need for improving national vaccination coverage levels. NIAM is co-sponsored by CDC and the National Public Health Information Coalition (NPHIC). The last week, August 21–27, focuses on vaccinations for preteens and teens. The theme for the week is “Ensure a healthy future with vaccines.”

From CDC:

Parents can do a number of things to ensure a healthy future for their child. One of the most important actions parents can take is to make sure their children are up to date on their vaccines. Preteens and teens need four vaccines to protect against serious diseases:

  • Meningococcal conjugate vaccine to protect against meningitis and blood infections (septicemia)
  • HPV (human papilloma virus) vaccine to protect against cancers caused by HPV
  • Tdap vaccine to protect against tetanus, diphtheria, and whooping cough (pertussis)
  • A yearly flu vaccine to protect against seasonal flu

Teens and young adults may also be vaccinated with a serogroup B meningococcal vaccine. Parents can send their preteens and teens to middle school and high school—and also off to college—protected from vaccine-preventable diseases by following the recommended immunization schedule.

The 2017 edition of the NIAM communications toolkit, put out by NPHIC in collaboration with CDC, contains key messages, vaccine information, sample news releases and articles, sample social media messages, links to web resources from CDC and other organizations, and logos, web banners, posters, and graphics to use with social media. The website also includes a place for you to share your NIAM activities and view what others are doing for NIAM, using the hashtag #NIAM17.

The first week of NIAM focused on babies and young children, the second week focused on pregnant women, and the third week focused on adults.

Related Links

Back to top

CDC issues guidance for tetanus-diphtheria vaccination during the current Td vaccine shortage

Td vaccine is expected to be in short supply through September 2017. To help healthcare professionals during this period, CDC has published Guidance for Tetanus-Diphtheria Vaccination during the 2017 Td Vaccine Shortage on its website.

Back to top

Seventh edition of Plotkin's Vaccines textbook now available for purchase

The seventh edition of the authoritative immunization textbook, Plotkin's Vaccines, is now available for purchase. A description from the publisher's web page is reprinted below.

From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.

New to this Edition
  • Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine
  • Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines
  • Features a new chapter on maternal immunization
  • Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices

Key Features

  • Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, treatment, epidemiology, and public health and regulatory issues—plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies
  • Analyzes the cost-benefit and cost-effectiveness of different vaccine options
  • Helps you clearly visualize concepts and objective data through an abundance of tables and figures

The authors are Stanley A. Plotkin, MD; Walter Orenstein, MD, DSc (HON); Paul A. Offit, MD, and Kathryn M. Edwards, MD.

Access additional information from Elsevier about the book, including the table of contents and ordering information.

Back to top

IAC Spotlight: Package Inserts & FDA Product Approvals and ACIP Recommendations web pages on are popular resources for IAC website visitors

Immunization providers around the country have given IAC feedback that the Package Inserts & FDA Product Approvals web page on is one of the most valuable resources for busy clinics that administer vaccines. This IAC web page provides direct links to where the package inserts are located on the websites of the manufacturers who make them available.
The ACIP Recommendations web page is another popular and important page. Here healthcare professionals can access all recommendations from the Advisory Committee on Immunization Practices (ACIP), sorted by either vaccine name or by date of publication.

Check these pages out, and see how easy it is to access the current information for any vaccine!

Back to top

GSK reports a potential for shipping delays of Menveo in August and September

CDC has published the following new information on its Current Vaccine Shortages & Delays web page.

GSK has reported that there is a potential for shipping delays of its meningococcal conjugate vaccine, Menveo ®, during late August and September. Sanofi has sufficient supplies of its meningococcal conjugate vaccine, Menactra ®, to address potential supply gaps during this period.

Back to top

National Adult Immunization and Influenza Summit publishes white paper on lowering the burden of adult disease through vaccination 

The National Adult and Influenza Immunization Summit (NAIIS) has published a white paper in Becker's Hospital Review titled "Lowering the Burden of Adult Disease, One Shot at a Time." This paper examines barriers hospitals and health systems face when trying to increase adult immunization rates, as well as opportunities for advancements, such as data transparency and immunization measures.

The report outlines:

  • Contributors to the low U.S. adult immunization rate
  • Industry expert insight into key challenges pushing adult vaccination programs to the wayside
  • Examples of three health systems boosting adult immunizations
  • Opportunities for accelerating vaccination efforts, with six action items for healthcare systems to leverage in order to boost adult immunization rates

To access this paper, fill out this short form, and a copy will be emailed to you to help your hospital or health system work toward better adult immunization rates.

Back to top

CDC reports error in HTML version of the Pertussis chapter in its "Pink Book"

CDC has announced that there was an error in the HTML version of the Pertussis chapter of Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"), 13th edition, as follows:

The Food and Drug Administration (FDA) approved age range for Adacel was incorrectly listed as 11 through 64 years in the 8th pink text box of this scrolling chapter. The correct age range is 10 through 64 years. This error has been corrected. The PDF and hardcopy versions of this content were always correct. The editors regret this error.
All the sections of "The Pink Book" (i.e., chapters, appendices, 2017 supplement) are available to download at no charge at You can select the PDF version by selecting that option in the drop-down menu labeled "Format" on the right-hand side of each chapter section.

Back to top


CDC and WHO report on progress toward polio eradication in Afghanistan in this week's MMWR and Weekly Epidemiological Report, respectively

CDC published Progress Toward Poliomyelitis Eradication—Afghanistan, January 2016–June 2017 in the August 18 issue of MMWR (pages 854–8). On the same day, WHO's Weekly Epidemiological Record published a similar article titled Progress towards poliomyelitis eradication: Afghanistan, January 2016–June 2017. A media summary of the MMWR article is reprinted below.

This report highlights polio eradication progress, challenges, and solutions implemented in Afghanistan during January 2016–June 2017. Thirteen cases were confirmed in 2016, a decrease from 20 cases reported in 2015. From January to June 2017, five cases were reported, compared with six during the same period in 2016. The polio program in Afghanistan has enhanced its management and accountability during vaccination campaigns and strengthened its coordination with Pakistan to track and vaccinate the children in high-risk populations that move between both countries. Vaccination teams have been increased at transit points in and out of areas that are inaccessible due to security challenges, as well as along travel routes and at border crossings. Community-based religious leaders and volunteers are deployed to increase acceptance of vaccination among families that had previously refused and to follow up after campaigns to identify and vaccinate children who were missed. 

Related Links

Back to top

WHO reports on human cases of influenza at the human-animal interface

The World Health Organization (WHO) published Human cases of influenza at the human-animal interface, January 2015–April 2017 in the August 18 issue of its Weekly Epidemiological Record. This report summarizes the epidemiological and virological features of the laboratory-confirmed human cases of infection with non-seasonal influenza viruses of animal origin, including avian influenza A(H5), A(H7) and A(H9N2) and swine-origin viruses. The second paragraph is reprinted below.

Since 2003, 859 human cases of A(H5N1) virus infection have been reported from 16 countries. In 2015, 145 cases were reported, the highest number reported in a calendar year. Most of these cases were reported in Egypt before May 2015; 6 were from China, 2 from Indonesia, and 1 from Bangladesh. In 2016, the number of reported cases (10) was the lowest since 2003 when 4 cases were reported. In the first quarter of 2017, only 3 cases were reported. All cases in 2016 and 2017 were reported from Egypt.

Related Links

Back to top

Ministry of Health of Saudi Arabia issues requirements and recommendations for entry visas for 2017 Hajj and Umra seasons

In the August 18 issue of its Weekly Epidemiological Record, the World Health Organization (WHO) announced that the Ministry of Health of Saudi Arabia had issued requirements and recommendations for entry visas for the Hajj and Umra seasons in 2017.

Access these requirements and recommendations

Back to top


International Vaccine Access Center adds impact studies modules for PCV and rotavirus to its VIEW-hub interactive platform

The International Vaccine Access Center (IVAC) has announced the addition of PCV and rotavirus modules to its VIEW-hub resource (Vaccine Information and Epidemiology Window). VIEW-hub is a publicly accessible, interactive platform that enables users to visualize real-time information on vaccine use, product type, coverage levels, and impact assessments worldwide. VIEW-hub users can visualize data about vaccine introductions, product usage, dosing schedules, access, coverage, and more for a number of vaccines, with custom queries and maps. 

Access the new VIEW-hub platform at

Access the VIEW-hub webpage on the IVAC website.

Related Links

Back to top

New edition of The Vaccine Handbook: A Practical Guide for Clinicians, a.k.a. "The Purple Book," by Dr. Gary Marshall available for purchase from IAC; free app for iPhones and iPads available from IAC

The 6th edition of The Vaccine Handbook: A Practical Guide for Clinicians ("The Purple Book") is considered a vital source of practical, up-to-date information for vaccine providers and educators. Now printed in color and updated with the latest vaccine information through early 2017, "The Purple Book" draws together the latest vaccine science and guidance into a concise, user-friendly, practical resource for the private office, public health clinic, academic medical center, and hospital.

The sixth edition of this valuable guide (592 pages) is available on IAC's website at The price of the handbook is $34.95 per copy, plus shipping charges. Order copies for your staff or for distribution at an upcoming conference.

Discount pricing is available for more than 10 copies. For quotes on larger quantities, email

Order your copy today! Click on the image below to visit the "Shop IAC: The Vaccine Handbook" web page.

Order your copy of The Vaccine Handbook today!

The Vaccine Handbook App for Apple iPhones and iPads is available free from IAC. Sorry, the app is not available for android devices. Book purchase is not necessary but registration to obtain the app is required.

The app is fully searchable, allows for bookmarking, highlighting and annotation, and contains hyperlinks to valuable content from nonprofit and governmental sources.

Click on the image below to visit the The Vaccine Handbook App page in the iTunes store.

Download new app!

About the Author
Gary S. Marshall, MD, is professor of pediatrics at the University of Louisville School of Medicine in Kentucky, where he serves as chief of the Division of Pediatric Infectious Diseases and director of the Pediatric Clinical Trials Unit. In addition to being a busy clinician, he is nationally known for his work in the areas of vaccine research, advocacy, and education.

Related Links

Back to top

Still available! IAC's sturdy laminated versions of the 2017 U.S. child/teen immunization schedule and the 2017 U.S. adult immunization schedule—order a supply for your healthcare setting today!

IAC's laminated versions of the 2017 U.S. child/teen immunization schedule and the 2017 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Both schedules are eight pages (i.e., four double-sided pages) and are folded to measure 8.5" x 11". 

Laminated Child and Teen Laminated Schedule

Adult Laminated Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top


Study published in Clinical Therapeutics found that access to pharmacies and other nontraditional settings helped increase adult influenza vaccination rates

On August 7, the journal Clinical Therapeutics published Impact of Pharmacist Immunization Authority on Seasonal Influenza Immunization Rates Across States by E.M. Drozd et al. The "Findings" and "Implications" sections of the abstract are reprinted below.

Overall, as states moved to allow pharmacists to administer influenza immunizations, the odds that an adult resident received an influenza immunization rose, with the effect increasing over time. The average percentage of people receiving influenza immunizations in states was 35.1%, rising from 32.2% in 2003 to 40.3% in 2013. The policy changes were associated with a long-term increase of 2.2% to 7.6% in the number of adults aged 25 to 59 years receiving an influenza immunization (largest for those aged 35–39 years) and no significant change for those younger or older.

These findings suggest that pharmacies and other nontraditional settings may offer accessible venues for patients when implementing other public health initiatives.

Access the complete article: Impact of Pharmacist Immunization Authority on Seasonal Influenza Immunization Rates Across States.

Back to top


NFID to offer September 6 webinar about protecting older adults against influenza 

The National Foundation for Infectious Diseases (NFID) will present a webinar titled "The Role of Healthcare Professionals in Protecting Older Adults against Influenza" on September 6 at 12:00 p.m. (ET). NFID medical director, William Schaffner, MD; Martha Gulati, MD, editor-in-chief of CardioSmart representing the American College of Cardiology; and Robert H. Hopkins, Jr., MD, professor of Internal Medicine and Pediatrics at the University of Arkansas for Medical Sciences representing the American College of Physicians, will discuss the critical role healthcare professionals play in protecting adults age 65 years and older against influenza. 

At the conclusion of this activity, participants will be able to:
  • Describe the phenomenon of immunosenescence and how the immune system grows weaker with aging
  • Discuss the importance of safe and effective influenza vaccines specifically developed for adults age 65 years and older
  • Describe resources available to help healthcare professionals talk with adult patients about specific influenza vaccines most beneficial for them

Access registration information.

Related Link

Back to top

Earn free continuing education credit by participating in “Increasing Adolescent Immunization Coverage” e-learning opportunity from the HPV Vaccination Roundtable and AHEC

A newly released e-learning module features a pediatrician, an OB-GYN, and a head and neck surgeon outlining the importance of vaccinating 11- and 12-year-old preteens against HPV-related cancers. This learning opportunity is sponsored by the HPV Vaccination Roundtable and the Area Health Education Centers (AHEC). “Increasing Adolescent Immunization Coverage” is a 40-minute online module for pediatric and primary care provider teams that provides information, guidance, and tools for quality improvement efforts to increase HPV vaccination by improving providers’ ability to: 
  • Describe the importance of the HPV vaccine
  • Implement the “same way, same day” approach to HPV vaccination for 11- and 12-year-olds
  • Answer parents’ questions accurately and succinctly
  • Introduce new practice tools to support HPV vaccination in the pediatric health care setting 

RNs/NPs, physicians, physician’s assistants, and pharmacists can earn a free hour of continuing education credit by viewing the CME module here. Non-credit seeking audiences can view the video here.

The National HPV Vaccination Roundtable is a coalition of public, private, and voluntary organizations and experts dedicated to reducing incidence of and mortality from HPV-associated cancer in the United States. 

The National AHEC Organization supports and advances the Area Health Education Center (AHEC) Network to improve health by leading the nation in recruitment, training, and retention of a diverse health work force for underserved communities.

Related Links

Back to top 

Reminder: Weekly CDC webinar series on "The Pink Book" chapter topics runs through October 11; register now 

CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (also known as "The Pink Book"). This is a live series of weekly 1-hour webinars that started June 14 and will run through October 11. Recordings of sessions will be available online within 2 weeks after each webinar. All sessions begin at 12:00 p.m. (ET). Continuing education will be available for each event.

The webinar series will provide an overview of vaccines and the diseases they prevent, general recommendations for vaccines, vaccination principles, and immunization strategies for providers. 

Registration and more information is available on CDC's Pink Book Webinar Series web page.

All the sections of "The Pink Book" (i.e., chapters, appendices, 2017 supplement) are available to download at no charge at

You can also order this resource from the Public Health Foundation for $40 plus shipping and handling. This print version does not include the 2017 supplement.

Back to top


Indiana Immunization Coalition to host October 5 meeting on the importance of standing orders for administering vaccines

The Indiana Immunization Coalition (IIC) will host a meeting on October 5 about the importance of incorporating standing orders for vaccines in clinical practice settings. The speakers, William Atkinson, MD, MPH, and Litjen Tan, MS, PhD, are nationally recognized experts on this topic. CME and CNE credits are being offered to participants.

Access more information about IIC's October 5 "Take a Stand" conference.

Related Links

Back to top

Washington Vaccine Update scheduled for October 27

WithinReach and the Immunization Action Coalition of Washington will be sponsoring the 2017 Washington Vaccine Update on October 27. This event will feature plenary speakers Dr. Orin Levine from the Gates Foundation and Seattle Mama Doc blogger Dr. Wendy Sue Swanson. The Washington Vaccine Update provides clinical information to healthcare providers who work with immunizations. Continuing education credits will be available for a variety of healthcare professionals. 

Access registration information.

Related Link

Back to top

ImmunizeOhio to host 13th Annual Statewide Immunization Conference on November 15

ImmunizeOhio will host its 13th Annual Statewide Immunization Conference on November 15 in Springfield. Speakers will present on the rate of exemptions in Ohio schools and a pediatrician's perspective on parental hesitancy, recently licensed vaccines and those in development, emerging patterns in global influenza, current influenza vaccine efficacy, and Zika virus.

The tentative agenda and registration information can be found at

Back to top


Question of the Week

Is there any plan to change the Influenza Vaccine Information Statement (VIS) for the 2017–2018 influenza season?   

The current influenza vaccine VIS may be used for the 2017–2018 influenza season. No changes are planned.  

About IAC's Question of the Week

Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.

We hope you enjoy this feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at

If you have a question for the CDC immunization experts, you can email them directly at There is no charge for this service.

Related Links

Back to top

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .